IL161066A0 - Method for preparing heparin from mast cell cultures - Google Patents

Method for preparing heparin from mast cell cultures

Info

Publication number
IL161066A0
IL161066A0 IL16106602A IL16106602A IL161066A0 IL 161066 A0 IL161066 A0 IL 161066A0 IL 16106602 A IL16106602 A IL 16106602A IL 16106602 A IL16106602 A IL 16106602A IL 161066 A0 IL161066 A0 IL 161066A0
Authority
IL
Israel
Prior art keywords
cell cultures
mast cell
preparing heparin
heparin
preparing
Prior art date
Application number
IL16106602A
Other languages
English (en)
Original Assignee
Aventis Pharma Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Sa filed Critical Aventis Pharma Sa
Publication of IL161066A0 publication Critical patent/IL161066A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P19/00—Preparation of compounds containing saccharide radicals
    • C12P19/26—Preparation of nitrogen-containing carbohydrates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C08—ORGANIC MACROMOLECULAR COMPOUNDS; THEIR PREPARATION OR CHEMICAL WORKING-UP; COMPOSITIONS BASED THEREON
    • C08B—POLYSACCHARIDES; DERIVATIVES THEREOF
    • C08B37/00—Preparation of polysaccharides not provided for in groups C08B1/00 - C08B35/00; Derivatives thereof
    • C08B37/006—Heteroglycans, i.e. polysaccharides having more than one sugar residue in the main chain in either alternating or less regular sequence; Gellans; Succinoglycans; Arabinogalactans; Tragacanth or gum tragacanth or traganth from Astragalus; Gum Karaya from Sterculia urens; Gum Ghatti from Anogeissus latifolia; Derivatives thereof
    • C08B37/0063—Glycosaminoglycans or mucopolysaccharides, e.g. keratan sulfate; Derivatives thereof, e.g. fucoidan
    • C08B37/0075—Heparin; Heparan sulfate; Derivatives thereof, e.g. heparosan; Purification or extraction methods thereof
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00—Preparation of peptides or proteins
    • C12P21/06—Preparation of peptides or proteins produced by the hydrolysis of a peptide bond, e.g. hydrolysate products

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IL16106602A 2001-10-22 2002-10-22 Method for preparing heparin from mast cell cultures IL161066A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0113606A FR2831186B1 (fr) 2001-10-22 2001-10-22 Production d'heparine a partir de cultures de mastocytes
PCT/FR2002/003617 WO2003035886A2 (fr) 2001-10-22 2002-10-22 Preparation d'heparine a partir de cultures de mastocytes

Publications (1)

Publication Number Publication Date
IL161066A0 true IL161066A0 (en) 2004-08-31

Family

ID=8868558

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16106602A IL161066A0 (en) 2001-10-22 2002-10-22 Method for preparing heparin from mast cell cultures

Country Status (18)

Country Link
US (1) US20050042733A1 (pt)
EP (1) EP1438415A2 (pt)
JP (1) JP2005506092A (pt)
KR (1) KR20040071127A (pt)
CN (1) CN1575341A (pt)
AR (1) AR036915A1 (pt)
BR (1) BR0213478A (pt)
CA (1) CA2462714A1 (pt)
CO (1) CO5570711A2 (pt)
FR (1) FR2831186B1 (pt)
HU (1) HUP0401794A2 (pt)
IL (1) IL161066A0 (pt)
MX (1) MXPA04003740A (pt)
NO (1) NO20041633L (pt)
NZ (1) NZ532414A (pt)
PL (1) PL368599A1 (pt)
WO (1) WO2003035886A2 (pt)
ZA (1) ZA200402304B (pt)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2853663B1 (fr) * 2003-04-14 2007-08-31 Aventis Pharma Sa Procede d'obtention de lignees de mastocytes a partir de tissus de porcs et procede de production de molecules de type heparine
FR2876386B1 (fr) * 2004-10-12 2007-04-06 Aventis Pharma Sa Lignees de mastocytes porcins produisant des molecules de type heparine
KR100688553B1 (ko) * 2005-06-22 2007-03-02 삼성전자주식회사 코어 사이즈를 감소시킨 반도체 메모리 장치
KR101447123B1 (ko) * 2014-02-27 2014-10-06 박상협 헤파린의 추출 방법
KR102104367B1 (ko) 2019-09-02 2020-04-24 팜앤바이오 주식회사 헤파린나트륨의 제조장치 및 제조방법
CN111979193A (zh) * 2019-09-27 2020-11-24 云南洛宇生物科技有限公司 大鼠骨髓源肥大细胞培养方法
CN110592165B (zh) * 2019-10-18 2021-04-27 福州大学 燕窝中硫酸乙酰肝素/肝素的提取方法与结构解析

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3016331A (en) * 1960-01-28 1962-01-09 Ormonoterapia Richter Spa Purification of heparin
WO1990014418A1 (en) * 1989-05-19 1990-11-29 The Uab Research Foundation Heparin-producing murine mastocytoma cell lines
EP0733207B1 (en) * 1993-12-10 1997-08-27 Genentech, Inc. Methods for diagnosis of allergy and screening of anti-allergy therapeutics
FI974321A0 (fi) * 1997-11-25 1997-11-25 Jenny Ja Antti Wihurin Rahasto Multipel heparinglykosaminoglykan och en proteoglykan innehaollande dessa
US6596705B1 (en) * 1998-02-09 2003-07-22 The Regents Of The University Of California Inhibition of L-selectin and P-selection mediated binding using heparin

Also Published As

Publication number Publication date
US20050042733A1 (en) 2005-02-24
AR036915A1 (es) 2004-10-13
ZA200402304B (en) 2004-10-07
EP1438415A2 (fr) 2004-07-21
MXPA04003740A (es) 2005-06-20
CN1575341A (zh) 2005-02-02
WO2003035886A2 (fr) 2003-05-01
NZ532414A (en) 2006-12-22
FR2831186A1 (fr) 2003-04-25
BR0213478A (pt) 2004-11-03
JP2005506092A (ja) 2005-03-03
KR20040071127A (ko) 2004-08-11
WO2003035886A3 (fr) 2004-02-26
NO20041633L (no) 2004-04-21
HUP0401794A2 (hu) 2004-11-29
FR2831186B1 (fr) 2004-06-18
CA2462714A1 (fr) 2003-05-01
PL368599A1 (en) 2005-04-04
CO5570711A2 (es) 2005-10-31

Similar Documents

Publication Publication Date Title
IL161858A0 (en) Cell culture process
EP1445022A3 (en) Multiwell cell growth apparatus
IL143421A0 (en) Method for culturing algae
IL194034A (en) Method for preparing o-desmethylvenlafaxine
HK1069578A1 (en) Method for preparing benzenesulfonyl compounds
HUP0400129A3 (en) Method for producing isocyanates
IL161066A0 (en) Method for preparing heparin from mast cell cultures
EP1245548A4 (en) PROCESS FOR THE MANUFACTURE OF VITROCERAMIC
EP1298117A3 (en) Method for preparing bromofluorenes
PL373093A1 (en) Method for introducing insulation elements
EP1229116A4 (en) PROCESS FOR THE PREPARATION OF CELL FRACTIONS CONTAINING HEMANGIOBLASTS
AU2002358848B2 (en) Method for preparing heparin from mast cell cultures
GC0000387A (en) Electrolytic cell regulation method
AU2002358848A1 (en) Method for preparing heparin from mast cell cultures
AU4663601A (en) Method for preparing 9-deoxo-8a-aza-(8a-alkyl)-8a-homoerythromycin derivativesfrom 9-deoxo-9(z)-hydroxyiminoerythromycin
HUP0500331A3 (en) Method for producing isocyanates
GC0000388A (en) Electrolytic cell regulation method
GB0123172D0 (en) Cell culture
GB0123171D0 (en) Cell culture
AUPR909801A0 (en) A method for culturing cells
EP1334093A4 (en) PROCESS FOR THE PREPARATION OF DL-ALPHA-TOCOPHEROL WITH HIGH YIELD
GB0103611D0 (en) Further improved method for detecting cells
HU0204443D0 (en) Process for preparing fluoroformates
AU2002351650A8 (en) Support method
AU2002367923A8 (en) Method for preparing 2-alkoxyphenoxyethanamines from 2-alkoxyphenoxyethylacetamides